Renz C

No ORCID on file · 1 paper in corpus

other 2026

Efficacy and safety of casirivimab/imdevimab (REGEN-COV) in pregnant individuals with COVID-19: Literature review and insights from the COVID-19 International Drug Pregnancy Registry

Obstetric Medicine ·doi:10.1177/1753495x251343113

INTRODUCTION: Casirivimab/imdevimab (CAS/IMD) comprises two monoclonal antibodies that neutralize SARS-CoV-2. Pregnant individuals were excluded from initial trials, limiting safety data. METHODS: The COVID-19 International Drug Pregnancy …